|
|
|
05.12.25 - 23:42
|
Emera Renews At-The-Market Equity Program (Business Wire)
|
|
|
HALIFAX, Nova Scotia--(BUSINESS WIRE)--Emera Incorporated (“Emera” or the “Company”) (TSX/NYSE: EMA) announced today that it has renewed its at-the-market equity program (the “ATM Program”) that allows the Company to issue up to C$600,000,000 of common shares (the “Common Shares”) from treasury to the public from time to time at varying prices, at the Company's discretion. Any Common Shares sold in the ATM Program will be sold through the Toronto Stock Exchange (the “TSX”), the New York Stock Exchange (the “NYSE”) or any other marketplace on which the Common Shares are listed, quoted or otherwise traded (collectively, the “Marketplaces”) at the time of sale.
The ATM Program continues to provide Emera with additional financing flexibility should it be required in the future. The volume and timing of distributions under the ATM Program, if any, will be determined at the Company's sole discretion. The Company has entered into an equity distribution agreement dated December 5, 20...
|
|
|
|
|
05.12.25 - 15:03
|
Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025 (GlobeNewswire EN)
|
|
|
VANCOUVER, British Columbia and BOSTON, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today announced new data highlighting its commitment in epilepsy, including interim 48-month data from its ongoing X-TOLE open-label extension (OLE) study of azetukalner in patients with focal onset seizures (FOS), multiple real world studies on the burden of depression and anti-seizure medication (ASM) titration in epilepsy, and new data for its pre-clinical program in Dravet syndrome. These data are being presented at the American Epilepsy Society Annual Meeting (AES 2025), taking place December 5-9, 2025 in Atlanta, Georgia....
|
|
|
|
|
|
|
04.12.25 - 17:48
|
The Best Stocks to Invest $1,000 in a TFSA Right Now (Fool)
|
|
|
Turn $1,000 in a TFSA into lifelong, tax-free growth with dependable income and durable compounders like Boralex, Winpak, and Brookfield Infrastructure.
The post The Best Stocks to Invest $1,000 in a TFSA Right Now appeared first on The Motley Fool Canada....
|
|
|
|
|
03.12.25 - 14:33
|
Xenon Announces Investor Webinar Highlighting Azetukalner and Epilepsy Data from AES 2025 (GlobeNewswire EN)
|
|
|
VANCOUVER, British Columbia and BOSTON, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today announced that the company will host an investor webinar focused on its data presentations at the American Epilepsy Society Annual Meeting (AES 2025), including new long-term data from the ongoing X-TOLE open-label extension study of azetukalner in focal onset seizures (FOS) and real world study data on the impact of depression and burden of titration in epilepsy. The webinar will also include an update on the company's progress preparing for commercialization of azetukalner....
|
|
|
|
|
03.12.25 - 02:00
|
2 Canadian Dividend Giants That Belong in Any Portfolio (Fool)
|
|
|
Two TSX dividend giants, TransAlta and BMO, offer resilient income and diversification that can anchor a portfolio through market ups and downs.
The post 2 Canadian Dividend Giants That Belong in Any Portfolio appeared first on The Motley Fool Canada....
|
|
|
|
|
|
|
|
|
|
|
|
|
28.11.25 - 13:03
|
Brookfield Infrastructure Renews Its Normal Course Issuer Bids (GlobeNewswire EN)
|
|
|
BROOKFIELD, NEWS, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Brookfield Infrastructure Partners L.P. (“BIP”) (NYSE: BIP; TSX: BIP.UN) today announced that the Toronto Stock Exchange (the “TSX”) accepted a notice filed by BIP of its intention to renew its normal course issuer bid for its outstanding limited partnership units (“LP Units”) and its cumulative class A preferred limited partnership units (“Preferred Units”, and together with LP Units, “Units”). Brookfield Infrastructure Corporation (“BIPC”) (NYSE/TSX: BIPC) also today announced that the TSX accepted a notice filed by BIPC of its intention to renew its normal course issuer bid for its outstanding class A exchangeable subordinate voting shares (“Exchangeable Shares”)....
|
|
|
27.11.25 - 15:36
|
Better Buy: Fortis Stock or Hydro One Stock? (Fool)
|
|
|
Fortis (TSX:FTS) and Hydro One (TSX:H) are great risk-off utility stocks to own when times get hard.
The post Better Buy: Fortis Stock or Hydro One Stock? appeared first on The Motley Fool Canada....
|
|
|
|
|
|
|
26.11.25 - 22:18
|
Brookfield Infrastructure Announces Intention to Redeem its Series 3 Preferred Units (GlobeNewswire EN)
|
|
|
BROOKFIELD, News, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Brookfield Infrastructure Partners L.P. (TSX: BIP.UN; NYSE: BIP) today announced that it intends to redeem all of its outstanding Cumulative Class A Preferred Limited Partnership Units, Series 3 (the “Series 3 Preferred Units”) (TSX: BIP.PR.B) for cash on December 31, 2025. The redemption price for each Series 3 Preferred Unit will be C$25.00. Holders of Series 3 Preferred Units of record as of November 28, 2025 will receive the previously declared final quarterly distribution of C$0.34375 per Series 3 Preferred Unit, payable on December 31, 2025....
|
|